About Pocket Naloxone
Pocket Naloxone is a company based in Bethesda (United States) founded in 2019 by Ashanthi Mathai and Kathryn Bowsher. Pocket Naloxone has raised $6.16 million across 1 funding round. The company has 3 employees as of December 31, 2024. Pocket Naloxone offers products and services including NaxSwab OTC. Pocket Naloxone operates in a competitive market with competitors including Celero Systems, Synens, NIRLAB, Labb and ION-GAS, among others.
- Headquarter Bethesda, United States
- Employees 3 as on 31 Dec, 2024
- Founders Ashanthi Mathai, Kathryn Bowsher
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pocket Naloxone Corp.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.16 M (USD)
in 1 rounds
-
Latest Funding Round
$6.16 M (USD), Series A
Mar 15, 2021
-
Investors
Not available
-
Employee Count
3
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pocket Naloxone
Pocket Naloxone offers a comprehensive portfolio of products and services, including NaxSwab OTC.
Nasal swab for rapid Naloxone administration to reverse opioid overdoses.
Funding Insights of Pocket Naloxone
Pocket Naloxone has successfully raised a total of $6.16M through 1 strategic funding round. The most recent funding activity was a Series A round of $6.16 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Pocket Naloxone
Investment portfolio details for Pocket Naloxone
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pocket Naloxone
Detailed financials for Pocket Naloxone
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pocket Naloxone Comparisons
Peer comparison for Pocket Naloxone
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pocket Naloxone
Pocket Naloxone operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celero Systems, Synens, NIRLAB, Labb and ION-GAS, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An ingestible device for detecting opioid overdoses is developed.
|
|
| Locked | Locked | Locked |
Provider of drug abuse detection devices
|
|
| Locked | Locked | Locked |
Offers handheld devices for instant material composition analysis using spectroscopy.
|
|
| Locked | Locked | Locked |
Mobile app for efficient drug testing and rapid results via various specimen types.
|
|
| Locked | Locked | Locked |
Develops customized analytical devices for medical, forensic, and quality assurance applications.
|
Detailed competitors of Pocket Naloxone
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pocket Naloxone
Complete news archive for Pocket Naloxone
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pocket Naloxone
Pocket Naloxone was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Pocket Naloxone is headquartered in Bethesda, United States. It is registered at Bethesda, Maryland, United States.
Ashanthi Mathai is the current CEO of Pocket Naloxone. They have also founded this company.
Pocket Naloxone is a funded company, having raised a total of $6.16M across 1 funding round to date.
As of Dec 31, 2024, the latest employee count at Pocket Naloxone is 3.
Pocket Naloxone was founded in 2019 and is based in Bethesda, United States. Medical devices approved by the FDA are developed by the company for managing opioid overdoses. A platform is provided that includes Naloxone Hydrochloride, which functions as an antidote to reverse opioid effects and prevent deaths. Operations focus on healthcare solutions in the opioid crisis sector.
Pocket Naloxone's top competitors include Celero Systems, Synens and NIRLAB.
Pocket Naloxone offers NaxSwab OTC.